Phase II study of pentostatin and intermittent high-dose recombinant interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome.

Foss, F M

Phase II study of pentostatin and intermittent high-dose recombinant interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Dec 1992 - 1907-13 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article

0732-183X

10.1200/JCO.1992.10.12.1907 doi


Adult
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Female
Humans
Interferon alpha-2
Interferon-alpha--administration & dosage
Male
Middle Aged
Mycosis Fungoides--drug therapy
Neoplasm Staging
Pentostatin--administration & dosage
Recombinant Proteins
Sezary Syndrome--drug therapy
Skin Neoplasms--drug therapy
Survival Analysis
Treatment Outcome